Today, we are taking an increasingly active role in managing our own health. As a result, the demand for consumer healthcare products is growing, particularly for affordable and effective over-the-counter products that consumers can use at home. With this trend on the rise, the number of start-ups looking to develop products within the consumer space is growing. How do you ensure that your company is up to industry standards to ensure a smooth transition to market? The road to retail has unexpected bumps, which means you’ll need to be prepared.
On March 9th, the experts at Johnson & Johnson Innovation invite you to an in-depth look into the process of commercializing a consumer healthcare product.
Whether your goal is to develop a pipeline through commercial launch or partner as early as possible, understanding market readiness and the variables that will impact time to market is critical for early-stage companies. With consumer and VC firms competing for the most promising science and technology, startups are expected to demonstrate a solid plan for launch and distribution.
These practical “how to take a concept to the retail shelves” presentations will highlight the following:
- Understanding market opportunity/business model
- Importance of formulation and supply at scale
- Avoiding regulatory path and safety hurdles
- Understanding your customer and your channel
- Funding your start-up through commercialization
This event is presented in partnership with::
Janice Cooney | Customer Development, Johnson & Johnson Consumer read bio»
Stefanie Dhanda | Consumer Scientific Innovation, Johnson & Johnson Innovation read bio»
Kate Luedtke | Research & Development, Johnson & Johnson Consumer read bio»
Lynne Szczepaniak | Vice President, Head Global Regulatory Affairs, Johnson & Johnson Consumer read bio»
Jessica Wadlow | Strategic Marketing and Business Models, Johnson & Johnson Consumer read bio»
|12:00 PM | Lunch|
|1:00 PM | Registration and Welcome|
|1:30 PM | Anticipating needs and creating solutions|
|- Understanding market opportunity
- Creating a business model
|2:00 PM | Developing your product|
|- Consumer centric product design
- Importance of designing for scale up
|2:30 PM | Q&A / Coffee Break|
|3:00 PM | Choosing the right path, regulatory path that is|
|- What do “Consumer Health Products” include – Product Classification & Interface
- Cosmetic v. Medical Device v. Drug and the impact on your advertising and promotion
- Stakeholders: Safety, Toxicity and Sustainability Issues
|3:30 PM | To the retail shelves|
|- Understanding the Shopper
- Understanding the Retailer
|4:00 PM | Funding your start-up through commercialization|
|- Consumer healthcare investors are hard to find
- Alternate ways to market
- How to get noticed by a strategic or a retailer
|4:30 PM | Q&A|
|5:00 PM | Networking Reception|
|6:00 PM | Program Close|
$35 | General Public
$20 | Student/Academic
$45 | At the door
MIT Koch Institute for Integrative Cancer Research
Auditorium (Room 76-156)
500 Main Street
Cambridge, MA 02142
Janice Cooney | Customer Development, Johnson & Johnson Consumer
Janice Cooney is Senior Director Customer Development, Johnson & Johnson Consumer, Inc. Janice is responsible for the CVS Health business, leading the team, business strategy and development across the Consumer Healthcare portfolio of OTC, Personal Care and Beauty products. She has held this position since 2011. Janice is also the Johnson & Johnson Corporate liaison for Minute Clinic. Janice has over two decades of CPG experience in Sales, Training, Professional Sales, Sales Administration, Brand Marketing and Customer Marketing with leading companies including Warner-Lambert and Pfizer. Janice sits on the NACDS Foundation Board and volunteers time to help support the Nowell Leadership Academy in Providence, RI. Janice received her undergraduate degree from Syracuse University and received an Executive Masters Healthcare Leadership from Brown University in 2015. She resides in East Greenwich, Rhode Island with her husband and their two children.
Connect with Janice:
Stefanie Dhanda | Consumer Scientific Innovation, Johnson & Johnson Innovation
Stefanie is Senior Director of Consumer Scientific Innovation at Johnson & Johnson Innovation, Boston. Stefanie leads Consumer sector efforts to grow and maintain a portfolio of innovative external partnerships, collaborations and investments for the benefit of J&J's Consumer businesses, which currently reach across broad and diverse sectors such as oral care, compromised skin, baby and maternal health, personal care and beauty, an OTC platform anchored in pain relief, cough/cold, and digestive health, as well as digital health platforms.
Previously, Stefanie was a Managing Director at Stonebridge Associates, a Boston-based investment banking firm that she helped found in 1996. She has over 20 years of experience in providing strategic and financial advisory services to small and midsized family-owned and growth companies in the consumer and healthcare sectors. Within that role she led mergers and acquisitions engagements, raised capital, defined business and financial strategy, performed complex due diligence and negotiated strategic alliances. In addition, Stefanie was independently consulting with several innovative startup and early-stage companies focused on the nutrition, health and wellness sector. Prior to Stonebridge, she worked at the Bank of New York.
Stefanie has a Bachelor of Science degree in Finance and Operations & Strategic Management from Boston College
Connect with Stefanie:
Kate Luedtke | Research & Development, Johnson & Johnson Consumer
Kate Luedtke is Associate Director, External Innovation for Johnson & Johnson Consumer and Personal Products Worldwide. She is currently leading a cross-franchise innovation platform focused on functional fragrances & flavors. She has held various R&D and marketing roles since joining Johnson & Johnson in 2001 and has a proven track record of coupling innovation with consumer insights to drive business results. Kate received a BS degree in chemical engineering from Princeton University and MBA from Temple University. She is co-inventor of several patents and was the recipient of the Johnson's Medal in 2008 for her work in developing JOHNSON'S® baby BEDTIME® routine.
Connect with Kate:
Lynne Szczepaniak | Vice President, Head Global Regulatory Affairs, Johnson & Johnson Consumer
Lynne is currently Vice President and Head of the Global Regulatory Affairs (GRA) organization for J&J’s Consumer sector which spans a broad portfolio of products and need states including OTC medicines, baby care, beauty care, skin care, oral care, wound care and eye care products. The talented global team of 300+ GRA staff in Lynne’s organization are responsible for all aspects of regulatory work throughout the product lifecycle – from strategic input on the upstream portfolio and product approval to support for products on the market. Lynne leads a global policy team with an outstanding track record of working closely with stakeholders, Trade Associations, and Health Authorities to drive a fact-based dialogue and shape policy on important issues.
Before joining J&J, Lynne was the Global Head of OTC Regulatory Affairs and Safety for Procter & Gamble Healthcare. Prior to her move to the OTC healthcare area, Lynne was the Global Head of a cross-functional organization for Procter & Gamble Pharmaceuticals which included Rx Regulatory Affairs, Pharmacovigilance, Regulatory Operations, Clinical Quality Assurance, and Clinical Development and Operations.
During her career Lynne has developed a reputation as an optimistic and pragmatic leader who balances regulatory realities with an eye to possibility. Lynne has significant experience building strong global organizations, developing regulatory strategies, and guiding successful interactions with Health Authorities and NGOs. Lynne has extensive experience managing alliances, including acquisitions, partnerships, join ventures, and divestitures. She has been a speaker on a range of topics, including Investigator Financial Disclosure, CDER/Sponsor Best Review Practices, and Advisory Committee Preparation and Conduct. Lynne holds a Bachelor of Science Degree in Clinical Nutrition. She was a member of the PhRMA RACC (Regulatory Affairs Coordinating Committee) where she was elected Vice Chair in 2003, served as Chair from 2004-2009, and was Past Chair from 2009 until she began supporting P&G’s OTC business. She currently is a member of the Consumer Healthcare Policy Association’s Regulatory Science Committee.
Connect with Lynne:
Jessica Wadlow | Strategic Marketing and Business Models, Johnson & Johnson Consumer
Jessica Wadlow is a marketing and innovation specialist with over 18 years of experience in creating innovation platforms, new product pipeline strategies and winning product concepts and marketplace strategies. Over the years, she has worked across a range of companies and brands in the consumer products, healthcare and finance sectors, most notably Neutrogena, Tylenol, JPMorgan Chase, and Walgreen’s Healthcare Clinics. Jessica currently works on the Johnson & Johnson Consumer Group’s External Innovation team where she is responsible for partnering with external companies to bring new technology to consumers. Prior to her current role, Jessica worked as a Director of Innovation for McNeil Consumer Healthcare as well as a Marketing Specialist for McKinsey Consulting. Jessica received her Masters of Business Administration from the Darden School at the University of Virginia in 2000 and a B.A. from Dartmouth College in Economics in 1996. She resides in Northern Virginia with her husband and 3 children.
Connect with Jessica:
Save This Event
When & Where
JLABS, part of Johnson & Johnson Innovation, LLC, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.